In addition, similar to other GLP-1 RAs, it affects different stages of the pathophysiological process of CVDs, from risk factors like dyslipidemia, hypertension, obesity, diabetes, and coronary artery atherosclerosis to more advanced stages such as myocardial ischemia, atherothrombosis, myocardial infarction, left ventricular remodeling, and death, without raising the risk of arrhythmia, hospitalization, or exacerbating heart failure [35, 41]
Want to track the changes objectively
We prescribe compounded semaglutide, not the brand-name products Wegovy or Ozempic
Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I
Musculoskeletal strain : Rapid weight loss associated with semaglutide may alter body mechanics, posture, and center of gravity, potentially contributing to mechanical lower back pain